Clindamycin Hydrochloride
- Product NDC
- 50090-7354
- 11-digit product format
- 500907354
- Labeler code
- 50090
- Product ID
- 50090-7354_d005db80-b81e-4587-8a6d-8004770e1720
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA216957
- Marketing category
- ANDA
- Marketing start
- 2023-03-10
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| T20OQ1YN1W | CLINDAMYCIN HYDROCHLORIDE | 21462-39-5 | CLINDAMYCIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7354-0 | 50090735400 | 30 CAPSULE in 1 BOTTLE (50090-7354-0) | 30 capsule | 2024-10-16 | No | No | Historical |
| 50090-7354-1 | 50090735401 | 45 CAPSULE in 1 BOTTLE (50090-7354-1) | 45 capsule | 2024-10-16 | No | No | Historical |
| 50090-7354-2 | 50090735402 | 16 CAPSULE in 1 BOTTLE (50090-7354-2) | 16 capsule | 2024-10-16 | No | No | Historical |
| 50090-7354-3 | 50090735403 | 40 CAPSULE in 1 BOTTLE (50090-7354-3) | 40 capsule | 2024-10-16 | No | No | Historical |
| 50090-7354-4 | 50090735404 | 20 CAPSULE in 1 BOTTLE (50090-7354-4) | 20 capsule | 2024-10-16 | No | No | Historical |
| 50090-7354-5 | 50090735405 | 3 CAPSULE in 1 BOTTLE (50090-7354-5) | 3 capsule | 2024-10-16 | No | No | Historical |